Skip to main content

Streptococcus strain D19T as a probiotic candidate to modulate oral health



As probiotics protect host cells, they are used to treat bacterial infections. It has been indicated that probiotics may prevent or reduce the attachment of pathogens to host cells. In this study, Streptococcus strain D19T was isolated from the oropharynx of a healthy child, and its adhesion performance and Staphylococcus aureus adhesion inhibition effect were analysed using human bronchial epithelial (16-HBE) cells, as an in vitro cell model. We evaluated the probiotic properties of the D19T strain based on its acid–base, bile salt, and lysozyme tolerance; antibacterial activity; cytotoxicity; antibiotic sensitivity; in vitro adhesion to 16-HBE cells; and competitive, exclusion, and displacement effects against S. aureus.


Streptococcus strain D19T showed tolerance to a PH range of 2–5 and 0.5–1% bile. However, it was more tolerant to 0.5% bile than to 1% bile. The strain also demonstrated an ability to adapt to maladaptive oropharyngeal conditions (i.e., tolerating 200 µg/mL lysozyme). It was resistant to 0.8 mM H2O2. The results also demonstrated that D19T exhibited inhibitory activities against various common pathogenic bacteria. Furthermore, D19T was not toxic to 16-HBE cells at different multiplicities of infection and was sensitive to most antibiotics tested. The adhesion rate of D19T cells to 16-HBE cells was 47% ± 1.2%, which was significantly higher than that of S. aureus to 16-HBE cells. The competition, exclusion, and displacement assay results showed that D19T has good inhibitory effect against S. aureus adhesion.


The present study revealed that Streptococcus strain D19T has the potential to be developed as a respiratory microbiota preparations.

Peer Review reports


Microbial communities exist on all surfaces of the human body, including the respiratory mucosa. Specialized bacterial communities inhabit particular sites of the respiratory tract and play important roles in maintaining human health [1]. Beneficial bacteria strongly affect the metabolism, nutrition, physiology, and immune functions of their hosts [2]. Improper use of antibiotics can lead to the development of drug-resistant strains [3].

Hundreds of microorganisms inhabit the human oral cavity [4].

Most of these microorganisms are commensals, while others are mutual symbionts with oral mucosal barrier functions. They confer resistance to pathogenic bacterial colonization in the host [5]. The Oropharyngeal microbiota dynamic and diverse. Various risk factors, such as poor dietary habits and poor oral hygiene, can alter the oral microbiota and disrupt the balance between symbiotic and pathogenic microorganisms [4]. These distortions may lead to opportunistic pathogens dominating the oral cavity, leading to pharyngitis, dental caries, gingivitis, and other oral diseases and infections [6]. The use of bacteria from the pharynx of healthy individuals as probiotics is considered safe [7]. Probiotics are living microorganisms that, when applied at appropriate amounts, can be beneficial to host health [8]. Probiotics can maintain the balance of the microbiota and inhibit the growth of pathogenic bacteria [9]. The respiratory tract, as a lumen that communicates with the outer environment, has dominant taxa in its microbiota, such as the partially isolated type A haemolytic Streptococcus spp. (S. salivarius and S. oralis) in the human oropharynx. These Streptococcus spp. are the dominant components of the microbiota in the upper respiratory tract and have a high affinity for human mucosa, protecting epithelial cells from pathogen adhesion [10]. The ability of probiotics to adhere to host cells is a classic selection criterion. Such probiotics can compete against pathogens for host cell binding sites and inhibit pathogenic bacterial adhesion [11]. In addition, the excellent adhesion ability of probiotics enables them to interact with the host and have beneficial effects. Staphylococcus aureus is a pathogenic bacterium in the mouth. It usually leads to microecological disorders and oropharyngeal dysfunction [12]. Therefore, the oropharyngeal tract is a potential target for developing new probiotic products. The aim of this study was to investigate Streptococcus oropharyngis strain D19T as a candidate probiotic and analyse its potential probiotic characteristics in vitro for further regulate oral health.


Strain identification

The 16 S rRNA gene sequence of the novel strain was obtained by sequencing (1433 bp), uploaded to the GenBank database (MN061029) and compared with the sequence in GenBank by the NCBI server using BLAST. As a result, compared with strain D19T, the type strains of Streptococcus with 16 S rRNA similarities greater than 97% were subsp. The results showed that Streptococcus oralis subsp. dentisani DSM 27088T, Strep-tococcus mitis ATCC49456T, Streptococcus pneumoniae ATCC 33,400 T, Streptococcus pseudopneumoniae ATCC BAA-960 T, and Streptococcus oralis ATCC 3503 T were most closely related to strain D19T.

Resistance to acidic pH, bile, lysozyme, and H2O2

We studied the potential probiotic properties of Streptococcus strain D19T. A probiotic must be resistant to oropharyngeal stress conditions to maintain its activity and viability in this site. Strain survivability at various pH levels and bile salt concentrations is shown in Fig. 1(a). D19T could tolerate a PH range of 2–5. D19T had greater resistance to 0.5% bile than to 1% bile. Moreover, it tolerated 0.08, and 0.8 mM H2O2, and 100 and 200 µg/mL lysozyme. Hence, D19T could overcome the hostile conditions of the oropharyngeal tract (Fig. 1(b) and 1(c)). It should be able to tolerate oral and digestive tract conditions, adhere to epithelial membranes, and compete with other microbes [19].

Fig. 1
figure 1

Growth curve plotting for Streptococcus strain D19T under different conditions. (a) Acidic pH and 0.5% or 1.0% bile. (b) 100 µg mL-1 or 200 µg/ mL-1 lysozyme. (c) 0.08 mM or 0.8 mM hydrogen peroxide (H2O2). OD = optical density

Antimicrobial activity

Table 1 shows the antagonism of Streptococcus strain D19T against eight common pathogenic bacteria. It was effective against S. aureus, Pseudomonas aeruginosa, Escherichia coli, Streptococcus pneumoniae, Proteus vulgaris, Streptococcus pyogenes, Acinetobacter baumannii, and Klebsiella pneumoniae.

Table 1 Antimicrobial activity of Streptococcus strain D19T

+++: bacteriostatic zone diameter ≥ 20 mm; ++: 15 mm ≤ inhibition zone diameter < 20 mm.

Antibiotic susceptibility testing

Table 2 shows the sensitivity of D19T to eleven different antibiotics. D19T was sensitive to penicillin, ampicillin, cefepime, cefotaxime, ceftriaxone, linezolid, clindamycin, chloramphenicol, minocycline, tetracycline and vancomycin. It was resistant to kanamycin and norfloxacin.

Table 2 Antibiotic susceptibility of Streptococcus strain D19T

Cytotoxicity assay

A key determinant of the probiotic effects of strains is their ability to adhere to host epithelial cells. Therefore, we aimed to determine the toxic effects of the probiotic strain on epithelial cells. As shown in Fig. 2, there was no significant change in cell viability after coincubation of D19T with human bronchial epithelial (16-HBE) cells at different multiplicities of infection (MOIs) for 12 h. However, after 24 h of incubation at an MOI of 0.2, D19T showed > 100% cell viability. In addition, at an MOI 2.0 or 20.0, D19T was not cytotoxic to 16-HBE cells. These findings are similar to those previously reported [13].

Fig. 2
figure 2

Effect of D19T on 16-HBE cell proliferation—at different multiplicities of infection (MOIs). The MOIs were = 0.2, 2, and 20. Means with different letters (a–f) differ significantly (P < 0.05)

Adhesion rate of strain D19T

The adhesion capacity of beneficial bacteria and pathogens may be affected by the in vitro cell line used for evaluation as well as the mechanisms underlying the interactions of the strain with the surface components of cells. As shown in Fig. 3, of the two strains tested, the adhesion rate of D19T was higher than that of S. aureus, with D19T showing an adhesion rate of over 40%.

Fig. 3
figure 3

Rate of adhesion of strain D19T and Staphylococcus aureus to 16-HBE cells

Effect of D19T on S. aureus adhesion to 16-HBE cells

The adhesion inhibition effect of probiotics on pathogens is also an important indicator of strain quality. As shown in Table 3, Streptococcus D19T prevented the adhesion of S. aureus through competitive action, with a relative competitive rate of 62.67%. Moreover, the adhesion rate of S. aureus to 16-HBE cells was significantly reduced (P < 0.01). Similarly, D19T reduced the adhesion of S. aureus to 16-HBE cells through displacement, with a relative displacement rate of 52.24%. However, D19T also reduced the adhesion of S. aureus to 16-HBE cells via exclusion. Studies have shown that probiotics compete with pathogens for adhesion sites because both probiotics and pathogens have similar types of adhesins on their surfaces. The inhibitory effect of D19T on S. aureus adhesion in this study was relatively satisfactory. However, further research is needed on adhesion inhibition mechanisms to provide a theoretical basis for the development of respiratory microbiota preparations.

Table 3 Effect of D19T on Staphylococcus aureus adhesion to 16-HBE cells


In this study, a total of 1080 strains of bacteria were isolated from the oral and pharyngeal parts of children, among which strain D19T had the best antibacterial effect. Choosing the most beneficial organisms in vitro, as an inexpensive and rapid detection approach, is more effective than choosing organisms in vivo. Although it is not possible to replicate all in situ conditions of the oropharyngeal ecosystem under in vitro conditions, in vitro detection is still a powerful approach for rapid screening of high potential strains, and extensive research can be conducted on many isolated strains to identify the specific characteristics of probiotic strains. Potential oral and pharyngeal probiotic strains are expected to tolerate oral and pharyngeal stress conditions, thereby improving the health of the host. The ability to resist acid, bile salt, H2O2, and lysozyme is considered a good indicator of the survival of oropharyngeal strains [13]. Antibacterial activity against pathogens is another important feature to be considered when selecting potential probiotic strains to maintain a healthy microbial balance in the body. This antagonistic activity is mainly attributed to the antibacterial substances or metabolites produced by probiotics, such as organic acids, bacteriocins, bacteriocin-like components, and H2O2 [14]. In this study, although the inhibition zones of the eight kinds of pathogenic bacteria were different, D19T showed antibacterial activity against all of the strains. Among the bacteria, the antibacterial activity against S. aureus and P. aeruginosa was the strongest, with an inhibition zone of > 20 mm, which may be attributed to the production of H2O2 or bacteriocin by D19T. An ideal probiotic strain for human use must be derived from humans, lack potential virulence genes, and be sensitive to commonly used antibiotics [15]. In this study, strain D19T was isolated from the oropharynx of a healthy child; it was identified as a Streptococcus mitis strain [16]. Owing to the difficulty in evaluating the adhesion performance of probiotics to host cells in vivo, many scholars worldwide use human-derived cell lines as in vitro models to study the adhesion ability of probiotics [17]. In recent years, multiple studies have reported that the microbiota in the lower respiratory tract is similar to that in the oropharynx; therefore, in this study, the human bronchial epithelial cell line 16-HBE was used as an in vitro cell model [18]. To understand the possible cytotoxic effects of strain D19T on 16-HBE cells, we evaluated the viability of 16-HBE cells in the presence of D19T at different MOIs (0.2, 2, and 20 ).We found that the D19T strain had no toxic effect on 16-HBE cells at an MOI of 2.0 or 20.0, similar to previous study results, indicating that it is relatively safe [19]. The susceptibility of all potential probiotic strains to a range of commonly used human antibiotics should be evaluated to identify potential probiotic strains with transferable antibiotic-resistance genes that may be harmful to the host [20]. The tested strain D19T was found to be sensitive to eleven commonly used antibiotics. Antibiotic-resistant bacteria have been generally considered unsafe for use as probiotics. Here, D19T was susceptible to most antibiotics, and the result was comparable to that of a previous study [21].The ability to adhere to host cells has been a classic selection criterion for potential probiotics; adherence may lead to brief colonisation, which helps promote immune regulation and stimulate the intestinal barrier and metabolic function. Jia et al. used fluorescence labelling to study the adhesion of the potential probiotic Lactobacillus salivarius AR809, isolated from the oropharynx, to FaDu cell monolayers. They found that it exhibited strong adhesion performance to FaDu cells. Additionally, one strain of S. oropharynges exhibited has a high adhesion ability, which was higher than previously reported values of 0.9% and 20% [22]. This higher result may be closely related to adhesins, secreted proteins related to adhesion, on the surface of the cells. The levels of these proteins are largely inconsistent, which leads to differences in the adhesion performance of strains. Adhesion and invasion of host tissues are essential steps in the pathogenesis of many pathogens and viruses [23]. It has been confirmed that probiotics can effectively inhibit cell binding and pathogen invasion [24]. In this study, strain D19T inhibited the adhesion of S. aureus to 16-HBE cells through competition, exclusion, and replacement. These results indicate that strain D19T may form a barrier through self-aggregation and adhesion mechanisms and may prevent potential pathogen binding to host cell receptors and coaggregation with potential pathogens, thereby protecting the host epithelium.


We isolated strain D19T from the oral cavity of a child and demonstrated its potential probiotic properties. Thus, it is a good probiotic candidate for improving oral health. Owing to its unique probiotic and functional properties, D19T has the potential to protect the oropharyngeal tract against invading pathogenic microbes, thereby preventing pharyngeal infections. Moreover, D19T has potential for use as a probiotic in health-promoting foods.


Bacterial strains and culture conditions

Bacterial samples were collected from a throat swab. D19T was obtained from the oropharyngeal mucosa of a healthy 6-year-old child. Staphylococcus aureus CGMCC10201, P. aeruginosa CGMCC10104, E. coli CGMCC10003, K. pneumoniae CGMCC31001, P. vulgaris CGMCC1.1651, E. coli cGMCC1.8726, A. baumannii CGMCC1.10395, and suppurative Streptococcus cGMCC9801 were purchased from the Shanghai Industrial Strain Preservation Center, China.

Streptococcus D19T (BHI; HyClone Laboratories, Logan, UT, USA) was incubated in culture medium at 37 °C for 24 h, and then stored at -40 °C for later use. The pathogens used in the antagonism and adhesion inhibition experiments were cultured in BHI medium for 6–8 h.

Isolation and identification of the strain

A throat swab sample was collected from the oropharynx of a healthy 6-year-old child from Shenyang, China, to isolate strain D19T. The sample was stored at -80°C until isolation and culture of D19T. The culture was placed in 1 mL of normal saline, mixed, and diluted by 10− 3 in a vortex mixer. Thereafter, 0.1 mL of the culture was evenly coated on BHI agar containing 5% defibrillated sheep blood. After incubation at 37°C for 24 h, white α haeemolytic colonies were extracted from the medium and purified using the continuous streaking technique. The phenotypic, phylogenetic, and genomic characteristics were analysed. The strain was identified using polymerase chain reaction (PCR). The total DNA was extracted and the primers used for 16S rRNA gene amplification were 27F/1492R (5’-agagtttgatcmtggctcag-3’ and 5’-ggytaccttgttacgactt-3’). PCR was performed using a 30 µL reaction mixture. The specific operation procedure was as follows: DNA degeneration (94 °C, 5 min), modification (94 °C, 30 s), annealing (56 °C, 30 s), extension (72 °C, 1 min 40 s), and final stretch (72 °C, 8–10 min). The PCR products were analysed using 1.5% agarose gel electrophoresis, and the sequencing of the amplicons was outsourced (Shanghai, China). The identification results showed that the isolate was a gram-positive, catalase-negative strain of a new Streptococcus species, closely associated with oral S. pneumoniae subspecies dentisani DSM27088, and was named Streptococcus shenyangsis sp. nov. [16].

Resistance to acid and bile salts

The pH tolerance assay reported by Jia et al. (2019) was used with slight modifications. An overnight D19T culture with a density of 108 CFU/mL was inoculated in either BHI broth at 3% (v/v), with the pH adjusted to 2.0, 3.0, 4.0, and 5.0 with 1 M HCl or BHI broth containing 0.5% (w/v) and 1% (w/v) bile. Uninoculated BHI broth (pH 7.0) served as the control. The inoculated broths were incubated at 37 °C for 24 h. Every 30 min, the optical density value at 600 nm (OD600nm) was measured using an automatic growth curve analyser (Bioscreen C, Helsinki, Finland) after shaking the culture for 10 s.

Resistance to lysozyme and H2O2

Overnight cultures of D19T (1 × 108 cfu/mL) were inoculated at 3% (vol/vol) into MRS broth containing lysozyme (100 and 200 µg/mL) or hydrogen peroxide (H2O2, 0.08 and 0.8 mM; Sangon Biotech), and incubated at 37 °C for 24 h. Inoculated MRS broth without lysozyme and H2O2 was used as a control. Every 30 min, the OD600nm value was measured using an automatic growth curve analyser after shaking for 10 s.

Antimicrobial activity

Strain D19T was cultured on a fibrillated sheep blood agar plate for 24 h, and monoclonal colonies were inoculated in BHI liquid medium and cultured on a 37 °C shaking table at 180 rpm for 24 h. The final concentration of the culture was adjusted to 1 × 109 CFU/mL. Simultaneously, the indicator strains (S. aureus, P. aeruginosa, E. coli, K. pneumoniae, K. vulgaris, E. coli, A. baumannii, and S. pyogenes) were cultured to the logarithmic phase, and their concentrations were adjusted to 1 × 106 CFU/mL. Finally, the inhibitory effect of strain D19T on the indicator strains was observed using the Oxford cup method. Specifically, 100 µL of indicator bacterial solution was coated on a nutritional agar plate with sterile cotton swabs. Four Oxford cups were placed on the agar plate with a pair of sterile tweezers at equal distances. Thereafter, 200 µL of culture suspension of each antagonistic strain was added into two cups, and an equal amount of BHI medium of equal amount was added into the other two cups as controls. Finally, the culture plate was placed horizontally in a 37 °C incubator for 18 h. Three plates were used for each indicator strain.

Antibiotic susceptibility

The antibiotic susceptibility of D19T was determined using the disc diffusion assay according to the 2018 recommendations of the Clinical Laboratory Standards Institute [25]. Colonies were selected and cultured for 24 h on agar plates containing 5% (w/v) defibrinated sheep blood and suspended in 5 mL of sterile normal saline solution with a turbidity of 0.5 McFarland. A bacterial suspension was applied to MH medium with sterile cotton swabs. The antibiotics tested were penicillin (30 µg), ampicillin (10 µg), cefepime (30 µg), cefotaxime (30 µg), ceftriaxone (10 µg), linezolid (30 µg), clindamycin(2 µg),chloramphenicol(30 µg),kanamycin(30ug), ,norfioxacin(10ug),minocycline(30ug), tetracycline(30ug)and vancomycin (30 µg). All assays were performed in triplicate.

Cytotoxicity assay

The cytotoxicity of D19T in 16-HBE cells was determined using the colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) [13]. The cells were seeded in a 96-well tissue culture plate at a density of 8 × 104 /well and grown until confluence. Thereafter, D19T was added at MOIs (bacteria:16-HBE cells) of 0.2:1, 2:1, and 20:1 before coincubation at 37 °C under 5% CO2 for 24 h. Subsequently, 10 µL of MTT (5 mg/mL) was added to each well, and the suspensions were incubated at 37 °C under 5% CO2 for 4 h. After incubation, 150 µL of dimethyl sulfoxide was added to each well and the formazan crystal product was completely dissolved by shaking for 10 min. The absorbance (A) of the sample in each well was measured at 570 nm using a microplate reader (TECAN Infinite 200 PRO; Beijing Long yue Biological Technology Development Co., Ltd., CA, USA) at 570 nm. Cell viability was calculated as follows:

Cell viability (%) = (Asample/Acontrol) × 100 (1);

where, Asample is the absorbance of 16-HBE cells coincubated with D19T and Acontrol is the absorbance of D19T alone.

Bacterial fluorescent labelling

The bacteria were labelled according to a previously reported method [26]. The bacterial strains were cultured to the middle and late periods of exponential growth and centrifuged at 4 °C for 10 min at 5000 × g. Thereafter, the supernatant was discarded; the pellet was washed twice with phosphate-buffered saline (PBS; pH 7.4), centrifuged at 4 °C for 10 min at 5000 × g, and mixed with carbonate buffer (0.5 mol/L, pH 9.5) to prepare 0.5 × 109 CFU/mL bacterial suspensions. FITC solution was added at a final concentration of 50–100 µg/mL in the bacterial suspension; the solution was stirred at room temperature for 1–2 h and centrifuged at 5000 × g for 10 min. Subsequently, the supernatant was discarded, and the pellet was washed twice with PBS and centrifuged at 5000 × g for 10 min. The precipitated bacteria were suspended in PBS to obtain a bacterial suspension with a concentration of 1 × 109 CFU/mL. The labelling was confirmed using fluorescence microscopy, and the bacterial suspension was stored at 4 °C, protected from light, until further use.

To observe the bacterial fluorescence signal, 5 µL of the labelled bacterial suspension was applied to a slide, and covered with a cover glass, and the bacterial fluorescence image was observed under a fluorescence microscope; a clear bacterial fluorescence field indicated successful labelling.

Cell culture assays

The 16-HBE cell line was purchased from Shenyang Medical College (Liaoning, China). The cells were cultured in endothelial cell medium (ECM; HyClone) containing 5% (v/v) foetal bovine serum, 1% (w/v) penicillin/streptomycin solution, and 1% (w/v) endothelial cell growth supplements at 37 °C under 5% CO2. The cells were then cultured in a 25-cm2 flask containing 0.25% (v/v) trypsin-EDTA solution (Sigma-Aldrich Corp., St. Louis, MO, USA) at 37 °C for 13 min and centrifuged (4000 × g, 4 °C, 1 min). The cells were inoculated in a six-well tissue culture plate at a density of 8 × 104/well and subcultured at 37 °C under 5% CO2 for 3 days until fusion.

Adhesion experiment

The method described by Jia et al. [13] was used. Cell cultures without bacteria were used as blank controls. The experimental group contained 100 µL of culture medium and 100 µL of fluorescently labelled D19T and S. aureus (1 × 109 CFU/mL) in 96-well plates. The plates were placed in an incubator at 37 °C under 5% CO2 for 2 h, and then, washed with sterile PBS three times. The unattached bacterial cells were eluted, 0.1 mL of trypsin was added to each well, and the plates were incubated for 13 min. After the complete exfoliation of cells, 0.4 mL of complete culture medium was added to terminate the reaction. The liquid was collected, and its fluorescence intensity was measured using a microplate reader. The excitation wavelength was set at 495 nm, and the emission wavelength was set at 530 nm. Relative fluorescence intensity was determined using 10 replicates for each group.

Calculation formula:

Adhesion rate of bacteria (%) = A/A0 × 100;

where, A is the relative fluorescence intensity of the cell suspension after the adherence of D19T and S. aureus cells to 16-HBE cells and elutes, and A0 is the relative fluorescence intensity of the cell suspension before the adherence of D19T and S. aureus cells to 16-HBE cells.

Competitive test

D19T cells (unlabelled), 16-HBE cells, and pathogenic bacteria (FITC-labelled) were incubated at 37 °C under 5% CO2 for 2 h. Thereafter, the samples were washed with sterile PBS twice to remove nonadherent cells and allowed to stand in the dark.

Exclusion test

D19T cells (unlabelled) and 16-HBE cells were incubated at 37 °C under 5% CO2 for 1 h. Thereafter, the cells were washed with sterile PBS twice to remove nonadherent cells. Subsequently, pathogenic bacteria (FITC-labelled) were added, and the samples were incubated under 5% CO2 at 37 °C for 1 h.

Displacement assay

Pathogenic bacteria (FITC labelled) and 16-HBE cells were coincubated at 37 °C under 5% CO2 for 1 h and washed with sterile PBS twice to remove nonadherent bacterial cells; thereafter, D19T cells (unlabelled) were added, and the samples were incubated at 37 °C under 5% CO2 for 1 h.

After the above treatment, 0.1 mL of pancreatic enzyme was added to each culture well and the samples were incubated for 13 min. After complete shedding of cells, 0.4 mL of complete culture medium was added to terminate the reaction. The suspension was collected, and its fluorescence intensity was measured using an enzyme-linked immunosorbent assay. Each group had six replicates and each culture well had one replicate.

Calculation formula: Adhesion rate (%) = A2 / A1 × 100;

where, A1 represents the relative fluorescence intensity of S. aureus adhering to 16-HBE cells in the presence of strain D19T, and A2 represents the relative fluorescence intensity of S. aureus adhering to 16-HBE cells in the presence of strain D19T.

Statistical analysis

All experiments were conducted independently, at least in triplicate. The data are presented as the mean ± standard deviation. The data were analysed using one-way ANOVA, and Duncan’s test was used to compare overall differences (P < 0.05).

Data availability

All data included in this study are available on request from the corresponding author.



3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide


Endothelial cell medium


Multiplicity of infection


Phosphate buffered saline


Polymerase chain reaction


  1. MAN W H, DE STEENHUIJSEN PITERS W A, BOGAERT D. The microbiota of the respiratory tract: gatekeeper to respiratory health [J]. Nat Rev Microbiol. 2017;15(5):259–70.

    Article  PubMed  Google Scholar 

  2. VASIEE A, FALAH F, BEHBAHANI B, et al. Probiotic characterization of Pediococcus strains isolated from Iranian cereal-dairy fermented product: Interaction with pathogenic bacteria and the enteric cell line Caco-2. J. 2020;130(5):471–9.

    CAS  Google Scholar 

  3. PRESTINACI F, PEZZOTTI P. Antimicrobial resistance: a global multifaceted phenomenon [J]. Pathog Glob Health. 2015;109(7):309–18.

    Article  PubMed  PubMed Central  Google Scholar 

  4. FAN X, PETERS B A, JACOBS E J, et al. Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults [J]. Microbiome. 2018;6(1):59.

    Article  PubMed  PubMed Central  Google Scholar 

  5. LóPEZ-LóPEZ A, CAMELO-CASTILLO A, FERRER M D, et al. Health-Associated Niche inhabitants as oral probiotics: the case of Streptococcus dentisani [J]. Front Microbiol. 2017;10:8379.

    Google Scholar 

  6. GAO L, XU T, HUANG G, et al. Oral microbiomes: more and more importance in oral cavity and whole body [J]. Volume 9. Protein & Cell; 2018. pp. 488–500. 5.

  7. R D G AB. M T, Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract [J]. 2018, 18(1): 653.

  8. JäGER R, MOHR A, CARPENTER K, et al. Int Soc Sports Nutr Position Stand: Probiotics [J]. 2019;16(1):62.

    Article  Google Scholar 

  9. MOHANTY D, PANDA S, KUMAR S et al. In vitro evaluation of adherence and anti-infective property of probiotic Lactobacillus plantarum DM 69 against Salmonella enterica [J]. 2019, 126:212–7.

  10. SIDJABAT H, GRAHN HåKANSSON E, CERVIN AJGA. Draft genome sequence of the oral commensal Streptococcus oralis 89a with interference activity against respiratory pathogens. J. 2016;4(1):e01546–15.

    Google Scholar 

  11. MONTEAGUDO-MERA A, RASTALL R, GIBSON G, et al. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. J. 2019;103(16):6463–72.

    CAS  Google Scholar 

  12. SCHENCK L P, SURETTE M G, BOWDISH D M E. Composition and immunological significance of the upper respiratory tract microbiota [J]. FEBS Lett. 2016;590(21):3705–20.

    Article  PubMed  Google Scholar 

  13. JIA G, CHE N, XIA Y et al. Adhesion to pharyngeal epithelium and modulation of immune response: Lactobacillus salivarius AR809, a potential probiotic strain isolated from the human oral cavity [J]. 2019, 102(8): 6738–49.

  14. SALEHIZADEH M, MODARRESSI M H, MOUSAVI S N, et al. Evaluation of lactic acid bacteria isolated from poultry feces as potential probiotic and its in vitro competitive activity against Salmonella typhimurium [J]. Vet Res Forum. 2020;11(1):67–75.

    PubMed  PubMed Central  Google Scholar 

  15. NAGPAL R, WANG S. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome [J]. Sci Rep. 2018;8(1):12649.

    Article  PubMed  PubMed Central  Google Scholar 

  16. LIU D, XIAO C, LI X, et al. Streptococcus shenyangsis sp. nov., a New species isolated from the Oropharynx of a healthy child from Shenyang China [J]. Curr Microbiol. 2021;78(7):2821–7.

    Article  CAS  PubMed  Google Scholar 

  17. XU H, JEONG H, LEE H et al. Assessment of cell surface properties and adhesion potential of selected probiotic strains [J]. 2009, 49(4): 434–42.

  18. CHANG A B, SMITH-VAUGHAN H, SLOOTS T P, et al. Upper airway viruses and bacteria detection in clinical Pneumonia in a population with high nasal colonisation do not relate to clinical signs [J]. Pneumonia. 2015;6(1):48–56.

    Article  PubMed  PubMed Central  Google Scholar 

  19. ZHANG W, XIAO C, LI S et al. Streptococcus strain C17 as a potential probiotic candidate to modulate oral health [J]. 2022, 74(6): 901–8.

  20. BAGCI U, OZMEN TOGAY S, TEMIZ A, et al. Probiotic characteristics of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum [J]. Folia Microbiol. 2019;64(6):735–50.

    Article  Google Scholar 

  21. KUEBUTORNYE F K A, LU Y, ABARIKE E D, et al. In vitro Assessment of the probiotic characteristics of three Bacillus species from the gut of Nile Tilapia, Oreochromis niloticus [J]. Probiotics and Antimicrobial Proteins. 2019;12(2):412–24.

    Article  Google Scholar 

  22. MERCIER-BONIN M, CHAPOT-CHARTIER M-P. Surface proteins of Lactococcus lactis: bacterial resources for Muco-adhesion in the gastrointestinal tract [J]. Front Microbiol. 2017;23:82247.

    Google Scholar 

  23. TSAI C-C, LAI T-M, LIN P-P, et al. Evaluation of lactic acid Bacteria isolated from fermented Plant products for antagonistic activity against urinary Tract Pathogen Staphylococcus saprophyticus [J]. Probiotics and Antimicrobial Proteins. 2017;10(2):210–7.

    Article  Google Scholar 

  24. ANGMO K. KUMARI A, SAVITRI, et al. Probiotic characterization of lactic acid bacteria isolated from fermented foods and beverage of Ladakh [J]. Volume 66. LWT - Food Science and Technology; 2016. pp. 428–35.

  25. QI H, LIU D, ZOU Y, et al. Description and genomic characterization of Streptococcus symci sp. nov., isolated from a child’s oropharynx [J]. Antonie Van Leeuwenhoek. 2021;114(2):113–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. VINDEROLA C G, MEDICI M. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria [J]. J Appl Microbiol. 2004;96(2):230–43.

    Article  PubMed  Google Scholar 

Download references


The authors thank the Shen Yang Science and Technology Bureau for funding this study.



Author information

Authors and Affiliations



CX: Conceptualisation (lead)WZ: Resources (lead); data curation (lead); formal analysis (lead); writing–original draft (lead); writing–review and editing (lead).

Corresponding author

Correspondence to Chun Ling Xiao.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval

The study was conducted in accordance with the guidelines of the ‘ ‘Helsinki Declaration’ ’ and approved by the ethics committee of Shenyang Medical College under number 2015052903.

Informed consent

The participating donors provided informed consent, and informed consent was obtained from their legal guardian.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, W.X., Xiao, C.L. Streptococcus strain D19T as a probiotic candidate to modulate oral health. BMC Microbiol 23, 339 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: